Oxytetracycline(OTCs) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Oxytetracycline(OTCs) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-49-1 | 1. BSA-Oxytetracycline(OTCs) 2. Anti-Oxytetracycline(OTCs) mouse monoclonal antibody |
$2709.00 |
GMP-SMT-49-2 | 1. OVA-Oxytetracycline(OTCs) 2. Anti-Oxytetracycline(OTCs) mouse monoclonal antibody |
$2709.00 |
GMP-SMT-49-3 | 1. BSA-Oxytetracycline(OTCs) 2. Anti-Oxytetracycline(OTCs) human monoclonal antibody |
$2709.00 |
GMP-SMT-49-4 | 1. OVA-Oxytetracycline(OTCs) 2. Anti-Oxytetracycline(OTCs) human monoclonal antibody |
$2709.00 |
GMP-SMT-49-Ag-1 | BSA-Oxytetracycline(OTCs) | $756.00 |
GMP-SMT-49-Ag-2 | OVA-Oxytetracycline(OTCs) | $756.00 |
GMP-SMT-49-Ab-1 | Anti-Oxytetracycline(OTCs) mouse monoclonal antibody | $1953.00 |
GMP-SMT-49-Ab-2 | Anti-Oxytetracycline(OTCs) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Oxytetracycline(OTCs)
Cat No. | GMP-SMT-49-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Oxytetracycline(OTCs) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Oxytetracycline(OTCs) had been validated with our anti-Hapten antibody Anti-Oxytetracycline(OTCs) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and
other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Oxytetracycline(OTCs)
Cat No. | GMP-SMT-49-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Oxytetracycline(OTCs) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Oxytetracycline(OTCs) had been validated with our anti-Hapten antibody Anti-Oxytetracycline(OTCs) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and
other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Oxytetracycline(OTCs) mouse monoclonal antibody
Cat No. | GMP-SMT-49-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation
(Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.3-0.5 |
Products description | The anti-Hapten antibody against hapten Oxytetracycline(OTCs) had been validated with our hapten hapten-carrier conjugates BSA-Oxytetracycline(OTCs) via competitive ELISA test. |
Application | ELISA tests and
other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Oxytetracycline(OTCs) human monoclonal antibody
Cat No. | GMP-SMT-49-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation
(Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.3-0.5 |
Products description | The anti-Hapten antibody against hapten Oxytetracycline(OTCs) had been validated with our hapten hapten-carrier conjugates BSA-Oxytetracycline(OTCs) via competitive ELISA test. |
Application | ELISA tests and
other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Figure: GeneMedi's GMP-SMT-48-Ab-1 is validated to detect the GMP-SMT-48-Ag-1 in ELISA. IC50=0.390 ppb.
Click to get more Data / Case study about the product.
Biomarker Information
1. What is Oxytetracycline (OTCs)?
Oxytetracycline (OTCs) is a potent antibiotic belonging
to the tetracycline family, making it a critical player in the realm of both human and
veterinary medicine. In the scientific context, OTCs has been extensively studied for its
broad-spectrum antimicrobial properties and has found applications in various fields, but its
primary use remains within veterinary medicine.
Within the tetracycline family, OTCs
stands out for its bacteriostatic nature, which means it inhibits the growth and reproduction of
susceptible microorganisms by interfering with their ability to synthesize proteins. This
mechanism of action is particularly valuable in the management of bacterial infections, as it
hinders the proliferation of pathogenic bacteria.
2. Why Measure Oxytetracycline
(OTCs)?
The measurement of Oxytetracycline is a vital scientific pursuit, and it finds
its significance in a variety of contexts:
a. Residue Monitoring:
One of the
primary reasons for quantifying Oxytetracycline is to monitor and regulate its presence in
animal-derived food products. When OTCs is administered to animals, trace amounts of the
antibiotic can potentially remain in products like meat, milk, and eggs. These residues must be
carefully monitored to ensure they comply with safety standards and regulations. The accurate
measurement of OTCs in these food items is crucial for safeguarding public health and ensuring
compliance with legal requirements.
b. Antibiotic Stewardship:
In the world of
veterinary medicine, the prudent use of antibiotics is paramount to prevent the development of
antibiotic resistance. Oxytetracycline, like other antibiotics, must be administered judiciously
to maintain its effectiveness. Precise measurement of OTCs enables veterinarians to determine
the appropriate dosage and treatment duration for animals. This, in turn, reduces the risk of
antibiotic resistance, which is a growing concern in both human and veterinary
medicine.
c. Quality Control:
In the pharmaceutical and veterinary product
manufacturing sectors, ensuring the correct concentration of Oxytetracycline is crucial.
Products that contain OTCs, such as antibiotics and vaccines, must be manufactured with
precision to ensure therapeutic efficacy. Accurate measurement of OTCs content is a fundamental
aspect of quality control, helping to guarantee that these products meet the necessary standards
and specifications.
d. Environmental Impact:
Beyond the realms of animal farming,
Oxytetracycline can also have environmental implications, especially in aquaculture. When used
in aquatic environments, it can lead to the contamination of water bodies. Excessive presence of
OTCs in aquatic ecosystems can disrupt the delicate ecological balance and harm aquatic life.
Precise measurement of OTCs is, therefore, vital in aquaculture to prevent these negative
environmental impacts.
In summary, the measurement of Oxytetracycline (OTCs) is a
multifaceted and critical endeavor with far-reaching implications. It ensures food safety,
promotes responsible antibiotic use, upholds quality control in pharmaceuticals, and prevents
environmental contamination. Our company specializes in providing the scientific tools and
expertise needed for accurate OTCs quantification, catering to the diverse requirements of these
important applications. We offer a range of solutions, including anti-OTCs antibodies and
competitive antigens, to meet the demands of scientific rigor, environmental sustainability, and
public health.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.